本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cytokinetics

33.23
-0.8800-2.58%
盘后33.230.00000.00%17:11 EDT
成交量:182.53万
成交额:6,073.68万
市值:39.76亿
市盈率:-6.49
高:34.54
开:34.05
低:32.89
收:34.11
52周最高:59.39
52周最低:29.31
股本:1.20亿
流通股本:1.19亿
量比:1.29
换手率:1.53%
股息:- -
股息率:- -
每股收益(TTM):-5.1237
每股收益(LYR):-5.2646
净资产收益率:-572.15%
总资产收益率:-24.87%
市净率:-10.78
市盈率(LYR):-6.31

数据加载中...

2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

重要事件披露

Current report, item 8.01
2020/02/04

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/23

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, item 8.01
2020/01/13

重要事件披露

Current report, items 2.02 and 9.01
2019/12/27

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/20

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/18

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/13

重要事件披露

Current report, items 1.01, 2.03, 8.01, and 9.01
2019/11/08

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/08

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/01

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/31

重要事件披露

Current report, items 2.02 and 9.01
2019/10/16

持股变动声明

Statement of changes in beneficial ownership of securities
2019/10/04

持股变动声明

Statement of changes in beneficial ownership of securities
2019/09/17

持股变动声明

Statement of changes in beneficial ownership of securities